Home

Race Oncology Limited (ASX:RAC) - Hidden Gems Webinar Presentation

PUBLISHED

2020-12-07

Content

[embed]https://player.vimeo.com/video/487937781[/embed]

Presenter – Dr Daniel Tillett – Race Oncology is an ASX listed precision oncology company with a Phase II/III cancer drug called Bisantrene. Bisantrene is a potent inhibitor of the Fat mass and obesity-associated (FTO) protein.